Multidisciplinary Approach to Reduce Cardiovascular Health Disparities

LifeBridge Health400 enrolled

Overview

The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke. Participants will engage in laboratory testing and health outcome assessments.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Acute Coronary Syndrome Multi Vessel Coronary Artery Disease Ischemic Stroke

Interventions

Life and Medication RecommendationsBEHAVIORAL

Based on obtained subjective and objective data from patient-filled questionnaire and laboratory testing respectively, lifestyle and medication recommendations will be provided for secondary prevention of cardiovascular and cerebrovascular diseases

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients ≥18 years of age admitted with ACS, AIS, or multi-vessel CAD * Competent mental condition to provide informed consent and able to participate in follow-ups Exclusion Criteria: * Pregnant women * Currently enrolled in an investigational drug or device trial * Undergoing treatment for neoplastic, autoimmune, or connective tissue disease * COVID-19 infection within 30 days of enrollment * Known history of hepatitis or HIV * Deemed unfit to participate according to the investigator * Known history of drug abuse * Known platelet count of \<100,000/mm3 * Hematocrit \< 25%

Locations (1)

Sinai Hospital of Baltimore

Baltimore, Maryland, United States

RECRUITING

Outcomes

Primary Outcomes

Differences in Platelet Fibrin Clot Formation (MA,mm)

Differences in Platelet Fibrin Clot Formation (MA,mm) Between Black and White Patients

Time frame: Baseline

Differences in Speed of Clot Formation (R, min)

Differences in Speed of Clot Formation (R, min) Between Black and White Patients

Time frame: Baseline

Secondary Outcomes

Major Adverse Cardiovascular Events Post Index Hospitalization

Major Adverse Cardiovascular Events (death, MI, stroke, unplanned target vessel revascularization, major bleeding) Post Index Hospitalization

Time frame: 3 and 12 months post index hospitalization

Central Contacts

Kevin Bliden, BS, MBA

CONTACT

4432441497 kbliden@lifebridgehealth.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.